EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 03 května 2024. Database contains 4691 unique substances/entries.

Filter the list

Je zobrazeno 4 201 - 4 400 položek z celkového počtu 4 691.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC
Ross River virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
rosin; colophony	-	-	Skin Sens. 1
Rocio	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rift Valley fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rickettsia typhi	-	-		B Bacteria and similar species
Rickettsia tsutsugamushi	-	-		B Bacteria and similar species
Rickettsia spp.	-	-		B Bacteria and similar species
Rickettsia rickettsii	-	-		B Bacteria and similar species
Rickettsia prowazekii	-	-		B Bacteria and similar species
Rickettsia montana	-	-		B Bacteria and similar species
Rickettsia conorii	-	-		B Bacteria and similar species
Rickettsia canada	-	-		B Bacteria and similar species
Rickettsia akari	-	-		B Bacteria and similar species
Rhodococcusequi	-	-		B Bacteria and similar species
Rhinoviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Reuviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Respiratory syncytial virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] show/hide Aluminosilicate Refractory Ceramic Fibres are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium and silicon are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm) c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight EC / List no: - \| CAS no: - Zirconia Aluminosilicate Refractory Ceramic Fibres are fibres covered by index number 650-017-00-8 in Annex VI, part 3, table 3.1 of Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, and fulfil the three following conditions: a) oxides of aluminium, silicon and zirconium are the main components present (in the fibres) within variable concentration ranges b) fibres have a length weighted geometric mean diameter less two standard geometric errors of 6 or less micrometres (µm). c) alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content less or equal to 18% by weight EC / List no: - \| CAS no: - Glass, oxide, chemicals This category encompasses the various chemical substances manufactured in the production of inorganic glasses. For purposes of this category, 'glass' is defined as an amorfous, inorganic, transparent, translucent or opaque material traditionally formed by fusion of sources of silica with a flux, such as an alkali-metal carbonate, boron oxide, etc. and a stabilizer, into a mass which is cooled to a rigid condition without crystallization in the case of transparent or liquid-phase separated glass or with controlled crystallization in the case of glass-ceramics. The category consists of the various chemical substances, other than by-products or impurities, which are formed during the production of various glasses and concurrently incorporated into a glass mixture. All glasses contain one or more of these substances, but few, if any, contain all of them. The elements listed below are principally present as components of oxide systems but some may also be present as halides or chalcogenides, in multiple oxidation states, or in more complex compounds. Trace amounts of other oxides or chemical compounds may be present. Oxides of the first seven elements listed* comprise more than 95 percent, by weight, of the glass produced. @Aluminium@Lead@Boron@Lithium@Calcium@Manganese@Magnesium@Molybdenum@Potassium@Neodymium@Silicon@Nickel@Sodium*@Niobium@Antimony@Nitrogen@Arsenic@Phosphorus@Barium@Praseodymium@Bismuth@Rubidium@Cadmium@Selenium@Carbon@Silver@Cerium@Strontium@Cesium@Sulfur@Chromium@Tellurium@Cobalt@Tin@Copper@Titanium@Germanium@Tungsten@Gold@Uranium@Holmium@Vanadium@Iron@Zinc@Lanthanum@Zirconium EC / List no: 266-046-0 \| CAS no: 65997-17-3	-	-	Carc. 1B
reaction products of paraformaldehyde with 2-hydroxypropylamine (ratio 1:1); [formaldehyde released from α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol]; [HPT]	-	-	Carc. 1B; Muta. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1A
reaction products of paraformaldehyde and 2-hydroxypropylamine (ratio 3:2); [formaldehyde released from 3,3'-methylenebis [5-methyloxazolidine]; formaldehyde released from oxazolidin]; [MBO]	-	-	Carc. 1B; Muta. 2; Acute Tox. 4; Acute Tox. 3; STOT RE 2; Skin Corr. 1B; Eye Dam. 1; Skin Sens. 1A
reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O, O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide	428-630-5	-	Skin Sens. 1
Reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates PDN 2287	417-450-2	-	Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts PRODUKT 1245	420-980-7	-	Eye Dam. 1
reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride	424-510-1	-	Eye Dam. 1
reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid PES-SOLID	420-070-1	-	Org. Perox. D; Acute Tox. 4; Skin Corr. 1A
reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate E-101	420-310-3	-	Acute Tox. 4
reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt YELLOW MGI 1301	424-250-9	-	Eye Dam. 1
reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) SHC 3000	401-530-9	-	Flam. Sol. 1; STOT SE 1; Acute Tox. 4
reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance	431-120-5	-	Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)	439-540-0	-	Skin Irrit. 2; Skin Sens. 1
reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. ORANGE LEP 2471	421-290-9	-	STOT RE 2
reaction mass of:5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)	435-180-3	-	Asp. Tox. 1; Skin Irrit. 2
reaction mass of:1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol GA161895; GLUCAMIDE	411-130-6	-	Eye Dam. 1
reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene); 1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol; 1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] P2-800; P2-935LV	415-870-0	-	Skin Sens. 1
reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1), O(2'))-chromate; trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''disulfamoyl-3,3''-disulfonato; bis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate; trisodium N(1')-N(2):N(1''')N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) NOIR SANDODERM HH 1050; SANDODERM BLACK HH 1050; SANDODERM BLACK R; SANDODERM BLACK R CONC.; SANDODERM SCHWARZ R; SANDODERM SCHWARZ R KONZ.	402-850-1	-	Eye Dam. 1
reaction mass of: trisodium 5{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate RED MDO 358	414-620-8	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)aniline]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{naphthalene-2,7-disulfonate; trisodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate	444-050-5	-	Eye Dam. 1
reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate	428-400-4	-	Eye Dam. 1
reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II); trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)	428-260-4	-	Eye Dam. 1
reaction mass of: trihexadecylmethylammonium chloride; dihexadecyldimethylammonium chloride ARQUAD 3.16	405-620-9	-	Eye Dam. 1
reaction mass of: triammonium; 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate	438-310-7	-	Self-react. C; Repr. 2; Acute Tox. 4; STOT RE 2
reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane	432-230-6	-	STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide; trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide EBO	417-540-1	-	Eye Dam. 1
reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate ITC 288/S	410-800-5	-	Skin Sens. 1
reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonate; 3-(2,5-disulfophenylazo)-4-hydroxy-7-{4-chloro-6-[4-(2-sulfoxyethylsulfonyl)phenylamino{-1,3,5-triazine-2-ylamino}naphthalene-2-sulfonic acid, sodium salt	429-440-5	-	Eye Dam. 1
reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid PRICARE	411-910-6	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II); sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) DRIMAREN NAVY R-GRL; NAVY 14 08 723	407-100-7	-	Skin Sens. 1
reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate	427-740-0	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate TASP	411-250-9	-	Skin Sens. 1
reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate EVAPORATED ELEMINOL JS-2 MATERIAL	410-230-7	-	Skin Corr. 1B; Skin Sens. 1
reaction mass of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate	433-860-4	-	Eye Irrit. 2; Skin Sens. 1
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane; sulfonamide	422-500-1	-	STOT RE 2
reaction mass of: pentasodium; 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl]azo]-7-sulfonato-1naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate; tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonatophenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate COLUMBIADUNKELBLAU R	415-350-3	-	Eye Dam. 1
reaction mass of: pentasodium; 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium - 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-}2-(sulfonatooxy)ethylsulfonyl{phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate	432-100-9	-	Eye Dam. 1
reaction mass of: pentasodium; 2-[[8-[[4-chloro-6-[[4-(2-sulfonatethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate	450-010-8	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)	423-010-0	-	Eye Dam. 1
reaction mass of: O, O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)	423-580-0	-	STOT RE 2
reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate COMPLEXING AGENT BN	410-650-0	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide; methacrylamide; 2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide; N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide VERNETZER TMAG	412-790-8	-	Carc. 1B; Muta. 2; STOT RE 2
reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; N-(3-dimethylamino-2-methyl-phenyl)-benzamide; N-(3-dimethylamino-3-methyl-phenyl)-benzamide PERGASCRIPT BLACK 20223 AMIDE INTERMEDIATE	420-600-1	-	STOT RE 2
reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine; N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine; N, N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine	414-340-6	-	Flam. Liq. 3; Acute Tox. 4; STOT SE 2; Eye Dam. 1; Skin Sens. 1
reaction mass of: N, N'-Ethane-1,2-diylbis(decanamide); 12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide; N, N'-Ethane-1,2-diylbis(12hydroxyoctadecanamide)	430-050-2	-	Skin Sens. 1
reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate REACTIVE YELLOW FC 75560	419-450-8	-	Skin Sens. 1
reaction mass of: mono-and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine, N-[3-(tridecyloxy)-propyl]; N, N-diorgano dithiocarbamate molybdenum complex	434-240-6	-	Skin Sens. 1
reaction mass of: hexyldioctylphosphineoxide; dihexyloctylphosphineoxide; trioctylphosphineoxide CYANEX (R) EXTRACTANT; CYANEX 923 EXTRACTANT	403-470-9	-	Skin Corr. 1B
reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane	434-420-4	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid PRICARE	411-860-5	-	Skin Sens. 1
reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium; 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate	426-840-1	-	Eye Dam. 1
reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate DYE K	402-660-9	-	Repr. 1B
reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate	435-960-3	-	Carc. 1B; Muta. 1B; Skin Sens. 1
reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)	427-140-9	-	Carc. 2
reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide; tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide; poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] OLOA 224 (OIL FREE)	420-470-4	-	Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
reaction mass of: di-(1-octane-N, N,N-trimethylammonium) octylphosphate; 1-octane-N, N,N-trimethylammonium di-octylphosphate; 1-octane-N, N,N-trimethylammonium octylphosphate NEWLON AM-92I	407-490-9	-	Acute Tox. 4; Skin Corr. 1B
reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine; methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine; 2-isopropyl-N-hydroxyethyl 1,3-oxazolidine	429-990-6	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol SP 7077	430-180-1	-	Skin Irrit. 2
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated) SP 7053	415-930-6	-	Repr. 2; Skin Sens. 1
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane	422-920-5	-	STOT RE 2
reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene; bis(N-octadecyl-N'-phenyleneureido)methylene; bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) MDI	406-550-1	-	Skin Sens. 1
reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate; isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate MCP 455	406-240-6	-	Flam. Liq. 3; Skin Corr. 1B
reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol A-88820.605	414-810-0	-	STOT RE 2; Eye Dam. 1
reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate AMMONIUM DIAS	407-320-3	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid DP 15	410-640-6	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate INTERMEDIAIRE AR HT 3728	410-065-0	-	Skin Sens. 1
reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one T-4240 FLUOROCHEMICAL URETHANE DERIVATIVE	413-640-4	-	STOT RE 2
reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol; 4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol RAS-5 1000 CPS; RAS-5 400 CPS; RAS-5 4000 CPS	417-470-1	-	Muta. 2; Skin Sens. 1
reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole; 1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole R 7623 TECHNICAL	403-250-2	-	Carc. 2; Repr. 1B; Acute Tox. 4
reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid	423-750-4	-	Eye Irrit. 2
reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 34 DIAZO	417-080-1	-	Self-react. D; Skin Sens. 1
reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde; 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde FORMYLTRICYCLODECEN, EXO	410-480-7	-	Skin Sens. 1
reaction mass of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo[}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetate)	431-440-5	-	Eye Dam. 1
reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine; 3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine DISPERSIONSROT 2754	411-880-4	-	Skin Sens. 1
reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid	435-440-6	-	Eye Dam. 1
reaction mass of: 3-[3-carbamoyl-5-(5-{4-chloro-6[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2oxo-1-pyridyl]propanoicacid, disodium salt	440-510-4	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol; 3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) ROT Y; RUBINOT Y; RUBINROT Y	408-240-1	-	Acute Tox. 4
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate ACRYLSKUM; T-2816 FOAMER	407-810-7	-	STOT RE 2
reaction mass of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)	442-800-6	-	Skin Irrit. 2
reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid MMA-10R	423-670-1	-	Eye Dam. 1; Skin Sens. 1
reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol; 4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol EUGEWHITE	412-020-0	-	Skin Sens. 1
reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate	419-000-0	-	Skin Sens. 1
reaction mass of: 2-ethylhexyl mono-D-glucopyranoside; 2-ethylhexyl di-D-glucopyranoside SPE 93279	414-420-0	-	Eye Dam. 1
reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate	428-050-2	-	Skin Sens. 1
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) RED E190	411-560-4	-	STOT RE 1; Skin Sens. 1
reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate F1 MINERAL FLOTATION COLLECTOR (40% HTEA.HCL)	405-720-2	-	Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid; potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate PIGMENTADDITIV P	411-310-4	-	Eye Dam. 1
reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol; 2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)ethoxy)ethanol; 3-(2,6-dichloro-4-nitrophenylazo)carbazol	429-590-1	-	Skin Sens. 1
reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl)oxo(phenyl)acetate	442-300-8	-	Skin Sens. 1
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile; 2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2,2'-dimethyl-2,2'-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)	429-710-2	-	Self-react. D; Acute Tox. 4
reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol]; formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2); formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) Z-19	414-520-4	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide	434-330-5	-	Carc. 2; Skin Sens. 1
reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol; 1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) GA1270; HOE S 4096	407-290-1	-	Eye Dam. 1
reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane; 1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane	426-530-6	-	Skin Irrit. 2
Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate HFR-990	423-180-6	-	STOT RE 2
reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane; 2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane	427-040-5	-	Skin Corr. 1B
reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6 trione; reaction mass of oligomers of; 3,5-bis(3-aminomethylphenyl)1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5(1H,3H,5H)-triazine-2,4,6-trione BLENDUR I VP KU 3-4519	421-550-1	-	Carc. 1B; Repr. 1B; Skin Sens. 1
reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride(or sulfonicacid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol	433-640-8	-	Pyr. Sol. 1
reaction mass of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate	442-480-8	-	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
reaction mass of: (3R)-[1S-(1α,2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus LOVASTATIN FREE ACID	415-840-7	-	Skin Sens. 1
reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/ [tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate HOSTACOR 4205 CONC.; HOSTACOR V 4205	413-500-2	-	Skin Irrit. 2; Eye Dam. 1
reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid MS6119	415-190-4	-	Skin Sens. 1
reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) EVERSORB 80; TINUVIN 1130; TINUVIN 213	400-830-7	-	Skin Sens. 1
reaction mass of trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate	436-890-6	-	Eye Dam. 1
reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate ETHOXYLATED POLYESTER RESIN	405-960-8	-	Skin Sens. 1
reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6',13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6',3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate	430-200-7	-	Eye Dam. 1
reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) EMULGATOR SWA; EMULVIN SWA	406-325-8	-	Acute Tox. 4
reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate UNISOL S	405-760-0	-	Eye Dam. 1; Skin Sens. 1
reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II) SUBSTANCE S166075	424-270-8	-	Eye Dam. 1
reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene; and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) BROWN JR 543	414-150-3	-	Skin Sens. 1
reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) X 3761	400-930-0	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 5-heptyl-1,2,4- triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine PK 323	401-940-8	-	Acute Tox. 4; Eye Irrit. 2
reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyltriphenylphosphonium, salt with 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene] diphenol (1:1)	-	-	Repr. 1B
reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl] phenolate (1:1)	-	-	Repr. 1B
reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers ADINE CP 31	401-740-0	-	Acute Tox. 4
reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate KAYARAD R-825	405-360-6	-	Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
reaction mass of 1-(2,3-epoxypropoxy)2,2-bis ((2,3-epoxypropoxy)methyl) butane and 1-(2,3-epoxypropoxy)-2-((2,3-epoxypropoxy)methyl)-2-hydroxymethyl butane	-	-	Muta. 2; Repr. 1B
reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5- oxo-2H-2-furylide namino)benzyl)phenyl)pyrrole-2,5-dione DESBIMID	401-970-1	-	Skin Sens. 1
reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or 2,6 or 3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride BRAUN HM 2763; BROWN HM 2763; BRUN HM 2763; BRUNO HM 2763	404-540-1	-	Skin Sens. 1
Rabies virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Rabbitpox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex	-	-	Acute Tox. 4
Puumala virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Providencia spp.	-	-		B Bacteria and similar species
Providencia rettgeri	-	-		B Bacteria and similar species
Providencia alcalifaciens	-	-		B Bacteria and similar species
Proteus vulgaris	-	-		B Bacteria and similar species
Proteus penneri	-	-		B Bacteria and similar species
Proteus mirabilis	-	-		B Bacteria and similar species
Prospect Hill virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino] benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts; sodium chloride	425-740-5	-	Eye Dam. 1
product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt BROWN JR 547	419-260-5	-	Eye Dam. 1
Prevotella spp.	-	-		B Bacteria and similar species
Powassan	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
potassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)	425-830-4	-	Eye Dam. 1
potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat C.I. REACTIVE RED 231	402-150-6	-	Eye Irrit. 2; Skin Sens. 1
potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate REAKTIVROT 2713	412-490-7	-	Skin Sens. 1
potassium 3-iodo-6-methylbenzenesulfonate	426-300-5	-	Eye Dam. 1
Porphyromonas spp.	-	-		B Bacteria and similar species
poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) RX-33	419-590-1	-	Flam. Sol. 1; Skin Sens. 1
Polioviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Plesiomonas shigelloides	-	-		B Bacteria and similar species
Plasmodium spp. (human and simian)	-	-		P Parasites
Plasmodium falciparum	-	-		P Parasites
Peptostreptococcus anaerobius	-	-		B Bacteria and similar species
pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate	414-910-4	-	Eye Dam. 1; Skin Sens. 1
pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1yl)benzene-1,4-disulfonate	418-270-7	-	Skin Sens. 1
Penicillium marneffei	-	-		F Fungi
Pasteurella spp.	-	-		B Bacteria and similar species
Pasteurella multocida	-	-		B Bacteria and similar species
Parainfluenza viruses types 1 to 4	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Paragonimus westermani	-	-		P Parasites
Paracoccidioides brasiliensis	-	-		F Fungi
Other Tacaribe complex viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other LCM-Lassa complex viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other known alphaviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other hantaviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other flaviviruses known to be pathogenic	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other Caliciviridae	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Other bunyaviridae known to be pathogenic	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Oropouche virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
organic compounds of mercury with the exception of those specified elsewhere in this Annex show/hide Diiodo(5-iodopyridin-2-amine-N1)mercury EC / List no: 298-602-3 \| CAS no: 93820-20-3 (2-ethylhexanoato)phenylmercury EC / List no: 236-326-7 \| CAS no: 13302-00-6 Mercury acetate EC / List no: 209-766-2 \| CAS no: 592-63-2 2-ethoxyethylmercury acetate EC / List no: 204-678-0 \| CAS no: 124-08-3 Mercury dioleate EC / List no: 214-741-4 \| CAS no: 1191-80-6 Otimerate sodium EC / List no: 240-572-0 \| CAS no: 16509-11-8 Dihydrogen [orthoborato(3-)-O]phenylmercurate(2-) EC / List no: 203-068-1 \| CAS no: 102-98-7 (phenylmercurio)urea EC / List no: 218-909-8 \| CAS no: 2279-64-3 Mercury, chloro(4-((2,4-dinitrophenyl)amino)phenyl)- EC / List no: - \| CAS no: 15785-93-0 (Trifluoromethyl)mercuric bromide EC / List no: - \| CAS no: 421-09-0 Hydrogen triiodomercurate(1-), compound with 3-methyl-3H-benzothiazol-2-imine (1:1) EC / List no: 276-613-4 \| CAS no: 72379-35-2 [2,5-dichloro-3,6-dihydroxy-2,5-cyclohexadiene-1,4-dionato(2-)-O1,O6]mercury EC / List no: 251-672-9 \| CAS no: 33770-60-4 Mercury difulminate EC / List no: 211-057-8 \| CAS no: 628-86-4 Mercurate(1-), (4-carboxylatophenyl)hydroxy-, hydrogen (1:1) EC / List no: - \| CAS no: 1126-48-3 2-ethoxyethylmercury chloride EC / List no: 204-670-7 \| CAS no: 124-01-6 Iodomethylmercury EC / List no: 205-600-8 \| CAS no: 143-36-2 Disuccinimidomercury EC / List no: 209-537-7 \| CAS no: 584-43-0 Hydroxymercury nitrile EC / List no: - \| CAS no: 31065-88-0 Mercury dithizonate EC / List no: 621-496-0 \| CAS no: 14783-59-6 Bromomethylmercury EC / List no: 208-057-5 \| CAS no: 506-83-2 Diisopropylmercury EC / List no: - \| CAS no: 1071-39-2 4-aminophenylmercury acetate EC / List no: 228-497-1 \| CAS no: 6283-24-5 Lactatophenylmercury EC / List no: 204-560-9 \| CAS no: 122-64-5 2-chloromercuriophenol EC / List no: 201-962-6 \| CAS no: 90-03-9 Bis(ethylthio)mercury EC / List no: - \| CAS no: 811-50-7 2-methoxyethylmercury chloride EC / List no: 204-659-7 \| CAS no: 123-88-6 Chloro-m-tolylmercury EC / List no: 227-722-0 \| CAS no: 5955-19-1 [μ-[[4,4'-(oxydiethylene) bis(dodecenylsuccinato)](2-)]]diphenyldimercury EC / List no: 299-418-6 \| CAS no: 93882-20-3 Bromoethylmercury EC / List no: 203-477-5 \| CAS no: 107-26-6 Lactic acid, mercury(2+) salt (2:1) (8CI) EC / List no: - \| CAS no: 814-82-4 Mercury, (acetato-O)(methylphenyl)- EC / List no: - \| CAS no: 1300-78-3 Mercaptomerin sodium EC / List no: 244-298-2 \| CAS no: 21259-76-7 1-cyano-3-(methylmercurio)guanidine EC / List no: 207-935-5 \| CAS no: 502-39-6 Naphthenic acids, mercury salts EC / List no: 215-651-8 \| CAS no: 1336-96-5 p-tolylmercury chloride EC / List no: 208-716-7 \| CAS no: 539-43-5 Di(acetato-O)anilinemercury EC / List no: 264-306-8 \| CAS no: 63549-47-3 Chloropropylmercury EC / List no: - \| CAS no: 2440-40-6 Mercury, (3-(2,5-dioxo-1-pyrrolidinyl)-2-methoxypropyl)hydroxy-, compd. with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione (1:1) EC / List no: - \| CAS no: 747-23-9 Chloromercuriferrocene EC / List no: 631-381-7 \| CAS no: 1273-75-2 Octadecanoic acid, mercury(1+) salt EC / List no: - \| CAS no: 86320-46-9 Bis(acetato-O)[μ-[1,3-dioxane-2,5-diylbis(methylene)-C:C',O,O']]dimercury EC / List no: 281-717-8 \| CAS no: 84029-43-6 Mercury, (acetato)pyridyl- (8CI) EC / List no: - \| CAS no: 1334-77-6 (bromodichloromethyl)phenylmercury EC / List no: 221-961-4 \| CAS no: 3294-58-4 [2-ethylhexyl hydrogen maleato-O']phenylmercury EC / List no: 248-559-1 \| CAS no: 27605-30-7 Amylmercury chloride EC / List no: - \| CAS no: 544-15-0 Chlormerodrin EC / List no: 200-530-4 \| CAS no: 62-37-3 Sodium 4-chloromercuriobenzoate EC / List no: 221-700-4 \| CAS no: 3198-04-7 Diiodobis(5-iodopyridin-2-amine)mercury dihydroiodide EC / List no: 264-100-8 \| CAS no: 63325-16-6 Hydrargaphen EC / List no: 238-107-1 \| CAS no: 14235-86-0 Hydrogen [metasilicato(2-)-O](2-methoxyethyl)mercurate(1-) EC / List no: 264-920-6 \| CAS no: 64491-92-5 basic phenylmercury nitrate EC / List no: 620-403-0 \| CAS no: 8003-05-2 Disodium tetra(cyano-C)mercurate(2-) EC / List no: 239-766-8 \| CAS no: 15682-88-9 Di(phenylmercury) dodecylsuccinate EC / List no: - \| CAS no: 24806-32-4 Mercury, (nitrate-O)(trifluoromethyl)- EC / List no: - \| CAS no: 461-40-5 Mercury, chloropyridinyl- EC / List no: - \| CAS no: 1334-75-4 Chloromethylmercury EC / List no: 204-064-2 \| CAS no: 115-09-3 Phenylmercury hydroxide EC / List no: 202-866-7 \| CAS no: 100-57-2 Diphenyl[μ-[(tetrapropenyl)succinato(2-)-O:O']]dimercury EC / List no: 248-355-2 \| CAS no: 27236-65-3 Mercury succinate EC / List no: 209-656-4 \| CAS no: 589-65-1 Mercurate(2-), tetraiodo-, copper(2+) (1:1), (T-4)- EC / List no: - \| CAS no: 27228-67-7 Mercury, bis(3-fluorophenyl)- EC / List no: - \| CAS no: 1961-02-0 mercury, chloro(3-hydroxyphenyl)- EC / List no: - \| CAS no: 70538-27-1 Bis(ethylmercuri)phosphate EC / List no: - \| CAS no: 2440-45-1 Phenylmercury nitrate EC / List no: 200-242-9 \| CAS no: 55-68-5 (3-chloro-4-hydroxyphenyl)mercury;hydrate EC / List no: - \| CAS no: 538-04-5 Phenylmercury stearate EC / List no: 203-217-0 \| CAS no: 104-59-6 [(2-hydroxyethyl)amino]phenylmercury acetate EC / List no: 263-211-9 \| CAS no: 61792-06-1 Diphenylmercury EC / List no: 209-606-1 \| CAS no: 587-85-9 Mercury(2+) (9Z,12Z)-octadeca-9,12-dienoate EC / List no: 231-814-6 \| CAS no: 7756-49-2 Mercury distearate EC / List no: 211-458-8 \| CAS no: 645-99-8 [μ-[metasilicato(2-)-O:O]]bis(2-methoxyethyl)dimercury EC / List no: 242-997-7 \| CAS no: 19367-79-4 Meralein sodium EC / List no: 224-498-6 \| CAS no: 4386-35-0 Mercury bis(trifluoroacetate) EC / List no: 236-250-4 \| CAS no: 13257-51-7 BMC EC / List no: 663-974-1 \| CAS no: 543-63-5 Bis(trichloromethyl)mercury EC / List no: 229-867-5 \| CAS no: 6795-81-9 Bis(lactato-O1,O2)mercury EC / List no: 242-667-2 \| CAS no: 18917-83-4 Chloro(trans-2-methoxycyclooctyl)mercury EC / List no: - \| CAS no: 5185-84-2 Mercuderamide EC / List no: 208-371-2 \| CAS no: 525-30-4 (neodecanoato-O)phenylmercury EC / List no: 247-783-7 \| CAS no: 26545-49-3 Hydrogen μ-hydroxy[μ-[orthoborato(3-)-O:O']]diphenyldimercurate(1-) EC / List no: 304-637-8 \| CAS no: 94277-53-9 Ethylmercury chloride EC / List no: 203-478-0 \| CAS no: 107-27-7 (4-((4-(Dimethylamino)phenyl)azo)phenyl)mercuric acetate EC / List no: 631-561-5 \| CAS no: 19447-62-2 Diethylmercury EC / List no: 211-000-7 \| CAS no: 627-44-1 Mercury bis(4-chlorobenzoate) EC / List no: 239-548-2 \| CAS no: 15516-76-4 Mercury hydrogen cyclohexanebutyrate EC / List no: 263-665-8 \| CAS no: 62638-02-2 Mercury bis(2-ethylhexanoate) EC / List no: 236-113-9 \| CAS no: 13170-76-8 Dimercury di(acetate) EC / List no: 211-161-3 \| CAS no: 631-60-7 (metaborato-O)phenylmercury EC / List no: 250-518-8 \| CAS no: 31224-71-2 Mercury, (3-((((3-carboxy-1-oxopropyl)amino)carbonyl)amino)-2-methoxypropyl)hydroxy- EC / List no: - \| CAS no: 140-20-5 Mercury, diheptyl- EC / List no: - \| CAS no: 51622-02-7 Phenylmercury propionate EC / List no: 203-094-3 \| CAS no: 103-27-5 Ethanethiolmercury chloride EC / List no: - \| CAS no: 1785-43-9 methylmercury nitrile EC / List no: - \| CAS no: 2597-97-9 Methylmercury hydroxide EC / List no: 214-667-2 \| CAS no: 1184-57-2 Dipropyl mercury EC / List no: - \| CAS no: 628-85-3 Ethylhydroxymercury EC / List no: - \| CAS no: 107-28-8 [μ-[orthoborato(2-)-O:O']]diphenyldimercury EC / List no: 228-465-7 \| CAS no: 6273-99-0 Sodium 4-hydroxymercuriobenzoate EC / List no: 205-340-5 \| CAS no: 138-85-2 Mercury, phenyl((2-phenyldiazenecarbothioic acid-kappaS) 2-phenylhydrazidato-kappaN2)- EC / List no: - \| CAS no: 12406-51-8 [μ-[(oxydiethylene but-2-enedioato)(2-)]]diphenyldimercury EC / List no: 301-791-8 \| CAS no: 94070-92-5 Phenyl(quinolin-8-olato-N1,O8)mercury EC / List no: 238-316-8 \| CAS no: 14354-56-4 Tetrakis(acetato-O)[μ4-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',4',5',7'-tetrayl)]tetramercury EC / List no: 259-075-5 \| CAS no: 54295-90-8 Thiomersal EC / List no: 200-210-4 \| CAS no: 54-64-8 4-Chloromercuriphenol EC / List no: - \| CAS no: 623-07-4 Mercury di(acetate) EC / List no: 216-491-1 \| CAS no: 1600-27-7 Tris(ethylmercury) phosphate EC / List no: 218-790-2 \| CAS no: 2235-25-8 2-Chloromercuri-4-nitrophenol EC / List no: - \| CAS no: 24579-90-6 (acetato-O)[3-(chloromethoxy)propyl-C,O]mercury EC / List no: 227-719-4 \| CAS no: 5954-14-3 3-(Acetoxymercuri)pyridine EC / List no: - \| CAS no: 102-99-8 Di-p-tolylmercury EC / List no: 208-672-9 \| CAS no: 537-64-4 Phenyl(tribromomethyl)mercury EC / List no: 221-963-5 \| CAS no: 3294-60-8 methylmercury salts EC / List no: 694-823-8 \| CAS no: 22967-92-6 Mercurous gluconate EC / List no: - \| CAS no: 63937-14-4 (oleato)phenylmercury EC / List no: 203-218-6 \| CAS no: 104-60-9 [N-(2-methylphenyl) benzenesulfone amidate-N] phenyl mercury EC / List no: - \| CAS no: 54129-03-2 (acetato-O)ethylmercury EC / List no: 203-688-2 \| CAS no: 109-62-6 Sodium timerfonate EC / List no: 227-741-4 \| CAS no: 5964-24-9 2-methoxyethylmercury acetate EC / List no: 205-790-2 \| CAS no: 151-38-2 [salicylato(2-)-O1,O2]mercury EC / List no: 227-760-8 \| CAS no: 5970-32-1 Mercury(2+) tetrakis(thiocyanato-N)cobaltate(2-) EC / List no: 248-602-4 \| CAS no: 27685-51-4 Butanoic acid, 4-((((2-methoxypropyl)amino)carbonyl)amino)-4-oxo-, mercury complex EC / List no: - \| CAS no: 72-58-2 [benzoato(2-)-C2,O1]mercury EC / List no: 227-228-5 \| CAS no: 5722-59-8 (acetato-O)diamminephenylmercury EC / List no: 269-247-1 \| CAS no: 68201-97-8 Dimethyl[μ-[sulphato(2-)-O:O']]dimercury EC / List no: 223-288-1 \| CAS no: 3810-81-9 Mercurobutol EC / List no: 207-869-7 \| CAS no: 498-73-7 Bromo(2-hydroxypropyl)mercury EC / List no: 242-613-8 \| CAS no: 18832-83-2 Mercury, [N-(2-methylphenyl)benzenesulfonamidato-N]phenyl- EC / List no: - \| CAS no: 2440-34-8 Bis[(trimethylsilyl)methyl]mercury EC / List no: 236-315-7 \| CAS no: 13294-23-0 Phenylmercury salicylate EC / List no: 248-828-3 \| CAS no: 28086-13-7 Dibutylrtut EC / List no: - \| CAS no: 629-35-6 Mercury, iodo(trifluoromethyl)- EC / List no: - \| CAS no: 421-11-4 4-(Chloromercuri)benzenesulfonic acid monosodium salt EC / List no: 683-356-5 \| CAS no: 14110-97-5 [μ-[(oxydiethylene phthalato)(2-)]]diphenylmercury EC / List no: 301-792-3 \| CAS no: 94070-93-6 6-methyl-3-nitrobenzoxamercurete EC / List no: 205-112-5 \| CAS no: 133-58-4 Ethyliodomercury EC / List no: 219-471-0 \| CAS no: 2440-42-8 (2,3,4,5,6-pentachlorophenoxy)-phenylmercury EC / List no: - \| CAS no: 1142-64-9 (2-carboxyphenyl)hydroxymercury EC / List no: 237-918-8 \| CAS no: 14066-61-6 Chloro[p-[(2-hydroxy-1-naphthyl)azo]phenyl]mercury EC / List no: 221-358-6 \| CAS no: 3076-91-3 Mercury, iodophenyl- EC / List no: 664-429-0 \| CAS no: 823-04-1 Dipotassium tetracyanomercurate EC / List no: 209-735-3 \| CAS no: 591-89-9 (Pentafluorophenyl)mercury EC / List no: - \| CAS no: 973-17-1 Phenylmercuric phthalate EC / List no: 664-337-0 \| CAS no: 84-70-8 Trimercury biscitrate EC / List no: 242-096-9 \| CAS no: 18211-85-3 Methylmercury benzoate EC / List no: 222-834-6 \| CAS no: 3626-13-9 Phenyl(trichloromethyl)mercury EC / List no: 221-960-9 \| CAS no: 3294-57-3 Phenylmercury benzoate EC / List no: 202-331-8 \| CAS no: 94-43-9 [2,2',2''-nitrilotri(ethanol)-N,O,O',O'']phenylmercury lactate EC / List no: 245-581-3 \| CAS no: 23319-66-6 Chloro-o-tolylmercury EC / List no: 220-469-7 \| CAS no: 2777-37-9 Methyl(pentachlorophenolato)mercury EC / List no: 227-596-7 \| CAS no: 5902-76-1 Mercury, (acetato-kappaO)(3-(chloromethoxy-kappaO)propyl-kappaC)- EC / List no: - \| CAS no: 1319-86-4 [naphthoato(1-)-O]phenylmercury EC / List no: 250-736-3 \| CAS no: 31632-68-5 (2-carboxy-m-tolyl)hydroxymercury, monosodium salt EC / List no: 258-195-5 \| CAS no: 52795-88-7 Mersalyl acid EC / List no: 207-637-5 \| CAS no: 486-67-9 2-hydroxy-5-(1,1,3,3-tetramethylbutyl)phenylmercury acetate EC / List no: 209-534-0 \| CAS no: 584-18-9 Phenylmercury chloride EC / List no: 202-865-1 \| CAS no: 100-56-1 4-Chloromercuribenzenesulfonate EC / List no: - \| CAS no: 554-77-8 Di-sec-butylmercury EC / List no: - \| CAS no: 691-88-3 Turpentine, Venice, sulfurized, reaction products with hydrogen tetrachloroaurate(-1), sulfurized turpentine oil and mercurous nitrate, mixed with mercurous oxide EC / List no: 293-784-0 \| CAS no: 91082-69-8 1H-Tetrazole, 5-nitro-, mercury(2+) salt EC / List no: - \| CAS no: 60345-95-1 Mercury(2+) chloroacetate EC / List no: 247-925-8 \| CAS no: 26719-07-3 Phenylmercury dimethyldithiocarbamate EC / List no: 251-026-6 \| CAS no: 32407-99-1 Bis(acetato-O)[μ-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthene]-2',7'-diyl)]dimercury EC / List no: 222-673-1 \| CAS no: 3570-80-7 Merbromin EC / List no: 204-933-6 \| CAS no: 129-16-8 Sodium [3-[[(3-carboxylatopropionamido)carbonyl]amino]-2-methoxypropyl]hydroxymercurate(1-) EC / List no: 231-532-3 \| CAS no: 7620-30-6 Mercury(1+) trifluoroacetate EC / List no: 220-875-4 \| CAS no: 2923-15-1 N-(ethylmercurio)toluene-4-sulphonanilide EC / List no: 208-231-0 \| CAS no: 517-16-8 (2',7'-dibromo-3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-4'-yl)hydroxymercury EC / List no: 259-779-2 \| CAS no: 55728-51-3 (dihydroxyphenyl)phenylmercury EC / List no: 248-426-8 \| CAS no: 27360-58-3 Amminephenylmercury(1+) acetate EC / List no: 245-006-6 \| CAS no: 22450-90-4 Di-o-tolylmercury EC / List no: 210-499-9 \| CAS no: 616-99-9 Chloro(hydroxyphenyl)mercury EC / List no: 215-308-2 \| CAS no: 1320-80-5 Mersalyl EC / List no: 207-748-9 \| CAS no: 492-18-2 Bis[(+)-lactato]mercury EC / List no: 251-657-7 \| CAS no: 33724-17-3 (lactato-O1,O2)mercury EC / List no: 242-673-5 \| CAS no: 18918-06-4 Mercury dibenzoate EC / List no: 209-499-1 \| CAS no: 583-15-3 Mercurate(1-), [dodecenylbutanedioato(2-)-O']phenyl-, hydrogen EC / List no: 304-575-1 \| CAS no: 94276-88-7 4-chloromercuriobenzoic acid EC / List no: 200-442-6 \| CAS no: 59-85-8 4-hydroxymercuric?phenyl sulfonic acid, sodium salt EC / List no: - \| CAS no: 73548-15-9 2-Acetoxymercurio-4-nitrophenol EC / List no: - \| CAS no: 63468-53-1 Mercury(1+) ethyl sulphate EC / List no: 275-904-3 \| CAS no: 71720-55-3 Mercury, bis(phenylmethyl)- EC / List no: 677-698-4 \| CAS no: 780-24-5 Phenylmercury acetate EC / List no: 200-532-5 \| CAS no: 62-38-4 Mercury, hydroxy(hydroxynitrophenyl)-, monosodium salt EC / List no: - \| CAS no: 1300-34-1 (acetato-O)methylmercury EC / List no: 203-547-5 \| CAS no: 108-07-6 Bis(5-oxo-L-prolinato-N1,O2)mercury EC / List no: 305-388-8 \| CAS no: 94481-62-6 Iodo(iodomethyl)mercury EC / List no: 205-485-4 \| CAS no: 141-51-5 (maleoyldioxy)bis[phenylmercury] EC / List no: 220-286-2 \| CAS no: 2701-61-3 Chloro-2-thienylmercury EC / List no: 227-481-1 \| CAS no: 5857-39-6 Benzenesulfonic acid, 4-hydroxy-3,5-diiodo-, mercury(2+) salt (1:1) EC / List no: - \| CAS no: 515-43-5 Bromophenylmercury EC / List no: 214-760-8 \| CAS no: 1192-89-8 Hydrogen [3-[(α-carboxylato-o-anisoyl)amino]-2-hydroxypropyl]hydroxymercurate(1-) EC / List no: 247-796-8 \| CAS no: 26552-50-1 Benzenesulfonic acid, p-hydroxy-, mercury deriv., disodium salt EC / List no: - \| CAS no: 535-55-7 Cyclopentanecarboxylic acid, 3-(((3-mercapto-2-methoxypropyl)amino)carbonyl)-2,2,3-trimethyl-, mercury complex EC / List no: - \| CAS no: 76-31-3 2-(ethylmercuriothio)benzoic acid EC / List no: 205-719-5 \| CAS no: 148-61-8 Bis(5-oxo-DL-prolinato-N1,O2)mercury EC / List no: 304-523-8 \| CAS no: 94276-38-7	-	-	Acute Tox. 2; Acute Tox. 1; STOT RE 2
Orf virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Orbiviruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Opisthorchis spp.	-	-		P Parasites
Opisthorchis felineus	-	-		P Parasites
Onchocerca volvulus	-	-		P Parasites
Omsk	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
oleum ... % SO3	-	-	Skin Corr. 1A; STOT SE 3
octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate H112339	413-550-5	-	Skin Irrit. 2; Eye Dam. 1
o-tolidine based dyes; 4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex show/hide Tetrasodium 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate] EC / List no: 200-786-7 \| CAS no: 72-57-1 2,2'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-nonylphenol] EC / List no: 268-048-7 \| CAS no: 67990-27-6 Disodium 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-diamino-5-methylbenzenesulphonate] EC / List no: 229-024-1 \| CAS no: 6405-94-3 N,N'-(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[2-[(2,4-dichlorophenyl)azo]-3-oxobutyramide] EC / List no: 227-783-3 \| CAS no: 5979-28-2 Benzamide, 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(imino(1-acetyl-2-oxo-2,1-ethanediyl)-2,1-diazenediyl))bis(4-methyl- EC / List no: - \| CAS no: 64441-14-1 N,N'-(3,3'-dimethylbiphenyl-4,4'-ylene)di(acetoacetamide) EC / List no: 202-111-1 \| CAS no: 91-96-3 Disodium 3,3'-((3,3'-dimethyl(1,1'-biphenyl)-4,4'-diyl)bis(azo)bis(4-aminonaphthalene-1-sulphonate) EC / List no: 213-594-3 \| CAS no: 992-59-6 N,N'-(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(3-hydroxynaphthalene-2-carboxamide) EC / List no: 223-007-2 \| CAS no: 3692-05-5 2,2'-[(3,3'-dimethyl-4,4'-biphenylylene)bis(azo)]bis[4-(1,1,3,3-tetramethylbutyl)phenol] EC / List no: 230-616-7 \| CAS no: 7218-82-8 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[imino(1-acetyl-2-oxoethane-1,2-diyl)azo]]bis[bis(3-aminopropyl)(p-methoxybenzyl)methylammonium] dichloride EC / List no: 255-154-3 \| CAS no: 40948-42-3 Tetrasodium 3,3'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4,5-dihydroxynaphthalene-2,7-disulphonate] EC / List no: 218-432-5 \| CAS no: 2150-54-1 Tetrasodium 6,6'-((3,3'-dimethyl-(1,1'-biphenyl-4,4'diyl)bis(azo)bis(4-amino-5-hydroxy-1,3-naphthalenedisulphonate) EC / List no: 206-242-5 \| CAS no: 314-13-6 2,2'-[(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-N-phenylbutyramide] EC / List no: 228-789-9 \| CAS no: 6358-88-9 N,N'-(3,3'-dimethyl[1,1'-biphenyl]-4,4'-diyl)bis[3-oxobutyramide], disodium salt EC / List no: 271-328-1 \| CAS no: 68540-94-3	-	-	Carc. 1B
o-dianisidine based azo dyes; 4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex show/hide N,N'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[3-oxobutyramide] EC / List no: 223-873-1 \| CAS no: 4104-12-5 2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(5-amino-4-hydroxy-, lithium sodium salt (1:1:3) EC / List no: - \| CAS no: 75659-72-2 2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)-3-oxobutyramide] EC / List no: 229-920-2 \| CAS no: 6837-37-2 1-Naphthalenesulfonic acid, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(4-hydroxy-, lithium salt (1:2) EC / List no: - \| CAS no: 75673-34-6 3,3'-dihydroxy-N,N'-(3,3'-dimethoxybiphenyl-4,4'-diyl)di-2-naphthamide EC / List no: 202-108-5 \| CAS no: 91-92-9 1-Naphthalenesulfonic acid, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(4-hydroxy-, lithium sodium salt (1:1:1) EC / List no: - \| CAS no: 75673-35-7 Tetrasodium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4,5-dihydroxynaphthalene-2,7-disulphonate] EC / List no: 224-091-3 \| CAS no: 4198-19-0 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-(p-tolyl)-3H-pyrazol-3-one] EC / List no: 229-986-2 \| CAS no: 6883-91-6 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide] EC / List no: 226-614-0 \| CAS no: 5437-88-7 Tetrasodium 2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[azo(2-amino-5-hydroxy-7-sulphonato-6,1-naphthylene)azo]]bis[5-nitrobenzoate] EC / List no: 274-429-9 \| CAS no: 70210-33-2 3,3'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[2,5-bis(p-nitrophenyl)-2H-tetrazolium] dichloride EC / List no: 214-665-1 \| CAS no: 1184-43-6 Copper, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(5-amino-4-hydroxy-2,7-naphthalenedisulfonate) morpholine ammonium lithium sodium complexes EC / List no: - \| CAS no: 96591-22-9 3,3'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[5-[4-(aminothioxomethyl)phenyl]-2-(p-nitrophenyl)-2H-tetrazolium] dichloride EC / List no: 253-257-8 \| CAS no: 36889-43-7 2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(5-amino-4-hydroxy-, lithium sodium salt (1:2:2) EC / List no: - \| CAS no: 75659-73-3 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxy-N-phenylnaphthalene-2-carboxamide] EC / List no: 233-354-1 \| CAS no: 10127-03-4 Tetralithium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate] EC / List no: 275-603-7 \| CAS no: 71550-22-6 Butanamide, 2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(N-(chlorophenyl)-3-oxo- EC / List no: - \| CAS no: 72845-99-9 Tetrasodium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-(acetylamino)-4-hydroxynaphthalene-2,7-disulphonate] EC / List no: 267-711-8 \| CAS no: 67906-44-9 2-Naphthalenecarboxamide, N,N'-(3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(3-hydroxy-, disodium salt EC / List no: - \| CAS no: 52735-88-3 3,3'-(3,3'-dimethoxy-4,4'-biphenylene)bis(2,5-diphenyl-2H-tetrazolium) chloride EC / List no: 217-488-8 \| CAS no: 1871-22-3 Disodium 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[iminocarbonyl(2-hydroxy-4,1-phenylene)azo]]bis(3-hydroxynaphthalene-1-sulphonate) EC / List no: 274-498-5 \| CAS no: 70247-69-7 2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-oxo-N-phenylbutyramide] EC / List no: 229-388-1 \| CAS no: 6505-28-8 2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2-methylphenyl)-3-oxobutyramide] EC / List no: 230-458-9 \| CAS no: 7147-42-4 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one] EC / List no: 229-389-7 \| CAS no: 6505-29-9 Disodium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis(4-hydroxynaphthalene-1-sulphonate) EC / List no: 219-382-7 \| CAS no: 2429-71-2 Tetrasodium 6,6'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-amino-5-hydroxynaphthalene-1,3-disulphonate] EC / List no: 220-026-8 \| CAS no: 2610-05-1 6,6'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[4-amino-5-hydroxynaphthalene-1,3-disulphonic] acid EC / List no: 223-333-5 \| CAS no: 3841-14-3 Tetrasodium 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate] EC / List no: 219-385-3 \| CAS no: 2429-74-5 5,5'-(3,3'-Dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(1-(4-nitrophenyl)-3-phenylformazan) EC / List no: - \| CAS no: 63469-14-7 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)diazo]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, sodium salt, compound with 2,2'-iminodiethanol EC / List no: 273-433-8 \| CAS no: 68966-43-8 2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(4-chlorophenyl)-3-oxobutyramide] EC / List no: 241-469-3 \| CAS no: 17453-73-5 3,3'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)diazo]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, sodium salt EC / List no: 273-439-0 \| CAS no: 68966-50-7 Tetrasodium 4,4'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonate] EC / List no: 265-533-5 \| CAS no: 65151-33-9 Benzoic acid, 4,4'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl(2-acetyl-1-oxo-2,1-ethanediyl)imino))bis-, 1,1'-dibutyl ester EC / List no: - \| CAS no: 820212-95-1 5,5'-diphenyl-3,3'-bis(4-nitrophenyl)-2,2'-(3,3'-dimethoxybiphenyl-4,4'-ylene)ditetrazolium dichloride EC / List no: 206-067-4 \| CAS no: 298-83-9 2,7-Naphthalenedisulfonic acid, 3,3'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(2,1-diazenediyl))bis(5-amino-4-hydroxy-, lithium sodium salt (1:3:1) EC / List no: - \| CAS no: 75752-17-9 Disodium 2,2'-[(3,3'-dimethoxy-4,4'-biphenylylene)bis[azo(methylimino)]]di(ethanesulphonate) EC / List no: 241-085-6 \| CAS no: 17011-51-7	-	-	Carc. 1B
O'nyong-nyong virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Norwalk virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Nocardia otitidiscaviarum	-	-		B Bacteria and similar species
Nocardia nova	-	-		B Bacteria and similar species
Nocardia farcinica	-	-		B Bacteria and similar species
Nocardia brasiliensis	-	-		B Bacteria and similar species
Nocardia asteroides	-	-		B Bacteria and similar species
Newcastle disease virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Neotestudina rosatii	-	-		F Fungi
Neisseria meningitidis	-	-		B Bacteria and similar species
Neisseria gonorrhoeae	-	-		B Bacteria and similar species

Je zobrazeno 4 201 - 4 400 položek z celkového počtu 4 691.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 03 května 2024. Database contains 4691 unique substances/entries.

Footer Nav Items